MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression

Jingjing Lin; Wangyue Wang; Qiaoqiao Xu; Jietong Ye

doi:10.1515/med-2016-0007

Open Medicine (Jan 2016)

MiR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression

Jingjing Lin,
Wangyue Wang,
Qiaoqiao Xu,
Jietong Ye

Affiliations

Jingjing Lin: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, 325000 PR China
Wangyue Wang: Department of Gastroenterology, The People’s Hospital of Lishui, 323000 PR China
Qiaoqiao Xu: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, 325000 PR China
Jietong Ye: Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, 325000 PR China

DOI: https://doi.org/10.1515/med-2016-0007
Journal volume & issue: Vol. 11, no. 1
pp. 31 – 35

Abstract

Read online

Increasing evidence showed that microRNAs (miRNAs) were implicated in the chemical resistance of human cancers. We intended to investigate the role of miR-218 in cisplatin sensitivity of esophageal cancer cells.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords